Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
15
TGA:15
Drug Approvals
SKYTROFA lonapegsomatropin 6.3 mg powder and solvent for solution for injection dual chamber glass cartridge (475726)
- Product Name
- SKYTROFA lonapegsomatropin 6.3 mg powder and solvent for solution for injection dual chamber glass cartridge
- Approval Date
- May 23, 2025
TGA
SKYTROFA lonapegsomatropin 4.3 mg powder and solvent for solution for injection dual chamber glass cartridge (445800)
- Product Name
- SKYTROFA lonapegsomatropin 4.3 mg powder and solvent for solution for injection dual chamber glass cartridge
- Approval Date
- May 23, 2025
TGA
SKYTROFA lonapegsomatropin 7.6 mg powder and solvent for solution for injection dual chamber glass cartridge (445803)
- Product Name
- SKYTROFA lonapegsomatropin 7.6 mg powder and solvent for solution for injection dual chamber glass cartridge
- Approval Date
- May 23, 2025
TGA
SKYTROFA lonapegsomatropin 13.3 mg powder and solvent for solution for injection dual chamber glass cartridge (445797)
- Product Name
- SKYTROFA lonapegsomatropin 13.3 mg powder and solvent for solution for injection dual chamber glass cartridge
- Approval Date
- May 23, 2025
TGA
SKYTROFA lonapegsomatropin 3 mg powder and solvent for solution for injection dual chamber glass cartridge (445798)
- Product Name
- SKYTROFA lonapegsomatropin 3 mg powder and solvent for solution for injection dual chamber glass cartridge
- Approval Date
- May 23, 2025
TGA
SKYTROFA lonapegsomatropin 9.1 mg powder and solvent for solution for injection dual chamber glass cartridge (445804)
- Product Name
- SKYTROFA lonapegsomatropin 9.1 mg powder and solvent for solution for injection dual chamber glass cartridge
- Approval Date
- May 23, 2025
TGA
SKYTROFA lonapegsomatropin 3.6 mg powder and solvent for solution for injection dual chamber glass cartridge (445799)
- Product Name
- SKYTROFA lonapegsomatropin 3.6 mg powder and solvent for solution for injection dual chamber glass cartridge
- Approval Date
- May 23, 2025
TGA
SKYTROFA lonapegsomatropin 5.2 mg powder and solvent for solution for injection dual chamber glass cartridge (445801)
- Product Name
- SKYTROFA lonapegsomatropin 5.2 mg powder and solvent for solution for injection dual chamber glass cartridge
- Approval Date
- May 23, 2025
TGA
SKYTROFA lonapegsomatropin 11 mg powder and solvent for solution for injection dual chamber glass cartridge (445796)
- Product Name
- SKYTROFA lonapegsomatropin 11 mg powder and solvent for solution for injection dual chamber glass cartridge
- Approval Date
- May 23, 2025
TGA
YORVIPATH palopegteriparatide 294 micrograms / 0.98 mL solution for injection in multidose pre-filled pen (443871)
- Product Name
- YORVIPATH palopegteriparatide 294 micrograms / 0.98 mL solution for injection in multidose pre-filled pen
- Approval Date
- Feb 19, 2025
TGA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found